Skip to main content

SurpassMD Review 2026: GLP-1 Pricing, Process & How It Compares

By the Peptide Dossier Editorial TeamUpdated How we source

Peptide Dossier and SurpassMD share ownership. We receive no referral fee or commission. Read our ownership disclosure.

SurpassMD is a GLP-1 telehealth platform. It offers compounded semaglutide as low as $114/month, tirzepatide as low as $177/month and oral semaglutide, with independent licensed provider review and cold shipping within 48 hours of approval. The offer stays flat across doses. Its appeal is a stated price, a direct online process and included nutrition guidance. Our GLP-1 Program Guide provides a framework to compare online care programs and included support.

What Is SurpassMD & How Does It Work?

SurpassMD is a digital health platform, not a medical practice or pharmacy. It connects patients with an independent licensed medical group whose clinicians review each intake, and with licensed 503A compounding pharmacies that dispense and ship medication when a prescription is issued. The platform operates in all 50 states plus Washington DC.

The process: complete an online assessment covering goals, health history, and current weight → an independent licensed provider reviews your information → if treatment is appropriate and a prescription is issued, medication ships cold-packed with tracking within 48 hours. There is no mandatory video visit for most patients, which keeps the process fast but also means less face time than consultation-heavy platforms.

SurpassMD is cash-pay only: no insurance, Medicare, or Medicaid billing. HSA/FSA cards and Klarna-style financing may be accepted at checkout.

SurpassMD Pricing: What $114/Month Covers

The advertised $114/month semaglutide and $177/month tirzepatide as-low-as rates reflect the longest subscription option without a prepayment lump sum. They include provider review, medication, supplies and shipping and stay flat as the prescribed dose changes. Patients can cancel anytime. This is a dose-independent offer, not an instruction to increase a dose on a fixed calendar.

Current competitor offers provide useful context without a universal cheapest ranking. Fridays’ pricing page promotes semaglutide from $99/month alongside standard-plan figures; Henry’s Programs page lists $297 monthly injectable semaglutide and product-specific prepaid options. TrimRx’s current offer panels show GLP-1 from $174 and GLP-1/GIP from $279, while its FAQ gives a broader $149 program minimum. SurpassMD’s $114 semaglutide offer is below the stated TrimRx GLP-1 panel and Henry injectable plan; its $177 tirzepatide offer is below TrimRx’s $279 GLP-1/GIP panel. Fridays’ $99 promotion is a lower semaglutide headline. The GLP-1 telehealth price comparison explains the broader comparison.

Medications: Semaglutide, Tirzepatide & an Oral Option

SurpassMD offers compounded semaglutide and tirzepatide, plus oral semaglutide for patients who prefer to avoid injections. In STEP 1, branded injected semaglutide 2.4 mg produced 14.9% mean weight loss at 68 weeks under the treatment-policy estimand in adults without diabetes. In SURMOUNT-1, injected tirzepatide 15 mg produced 20.9% under the treatment-regimen estimand and 22.5% under the efficacy estimand at 72 weeks in adults without diabetes. These are different trials and analyses; they did not establish the same outcomes for SurpassMD compounds or oral tablets. Original STEP 1; original SURMOUNT-1.

Important: compounded versions of both drugs are prepared by state-licensed pharmacies but are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. For the regulatory background, see our guide to whether compounded semaglutide is legal in 2026.

Pros & Cons of SurpassMD

Pros

  • Flat semaglutide as low as $114/mo and tirzepatide as low as $177/mo
  • No increase in the offer price as dose changes
  • Cold shipping within 48 hours of approval
  • All 50 states plus DC coverage
  • Oral semaglutide option for patients who prefer no injections
  • Nutrition guidance included
  • HSA/FSA and Klarna-style options; cancel-anytime; no prepayment lump sum

Cons

  • Cash-pay; no insurance, Medicare or Medicaid billing
  • Compounded medicines are not FDA-approved
  • Newer platform; testosterone and other peptide therapies not yet available

How SurpassMD Compares to Other GLP-1 Platforms

SurpassMD competes on its stated flat $114/$177 offers, oral semaglutide, nutrition guidance and cold dispatch within 48 hours. Fridays’ strengths are coaching and brand-name insurance navigation. Henry offers compounded oral tirzepatide with different formulation and package terms. TrimRx advertises all-dose base plans and multiple offers. Remedy emphasizes unlimited clinician contact and 28-day billing; its current public dollar quote was not established in this review.

Head-to-head breakdowns: SurpassMD vs Henry Meds, SurpassMD vs TrimRx, SurpassMD vs Fridays, and SurpassMD vs Remedy Meds. For the full field, see the best GLP-1 telehealth providers roundup.

Who Should (and Shouldn't) Use SurpassMD

SurpassMD suits price-sensitive, self-directed patients who want its stated flat offer, included nutrition guidance, oral semaglutide option and a direct online process. Fridays may fit someone who wants structured 1:1 coaching or insurance navigation; Henry may fit someone specifically considering its oral tirzepatide formulation. The independent provider determines clinical suitability and the exact formulation.

If you are comparing your first GLP-1, start with semaglutide vs tirzepatide to pick the molecule before you pick the platform.

Frequently Asked Questions

SurpassMD advertises compounded semaglutide as low as $114/month and tirzepatide as low as $177/month for eligible patients, flat across doses. The rate reflects the longest subscription option without a prepayment lump sum. Provider review, medication, supplies and cold shipping are included; oral semaglutide is also offered. The subscription is cancel-anytime.

SurpassMD is a digital health platform, connecting patients with independent licensed clinical review and licensed 503A compounding pharmacy fulfillment. It operates in all 50 states plus DC. It is not itself a medical practice or pharmacy, a prescription is not guaranteed and compounded medicines are not FDA-approved. It is a newer brand as of 2026.

SurpassMD advertises cold-chain shipping within 48 hours of provider approval, with tracking, to all 50 states plus DC. That is a dispatch commitment rather than a guarantee of arrival within 48 hours. Provider and pharmacy timing and carrier delivery are separate parts of fulfillment.

No. SurpassMD is cash-pay and does not bill insurance, Medicare or Medicaid; it is also not available to Medicare or Medicaid beneficiaries. HSA/FSA and Klarna-style financing options are offered at checkout. Someone seeking help pursuing insured brand-name medication may prefer a service such as Fridays or their own clinician.

Its GLP-1 offering includes compounded injectable semaglutide as low as $114/month, injectable tirzepatide as low as $177/month and oral semaglutide for patients who prefer to avoid injections. A licensed provider decides which, if any, is appropriate. Testosterone and other peptide therapies are not yet available on the platform.

No. An independent licensed provider reviews the intake, health history, medicines and contraindications before deciding whether treatment is appropriate. Pregnancy or breastfeeding, prior pancreatitis and the exact product and formulation need individual assessment. MTC/MEN2 are labeled contraindications for specified approved products; breastfeeding and prior pancreatitis should not be treated as interchangeable universal contraindications across every GLP-1 formulation.

SurpassMD advertises cancel-anytime subscriptions. Cancel before the next billing cycle, retain the confirmation and review the applicable account terms. Stopping treatment is a separate clinical decision from canceling a subscription or changing platforms; discuss the treatment plan with the prescriber.

SurpassMD’s flat as-low-as offers are $114/month semaglutide and $177/month tirzepatide, with 48-hour cold dispatch and nutrition guidance. Checked October 28, Fridays advertises a $99 semaglutide promotion alongside standard plans, Henry’s Programs page lists $297 monthly injectable semaglutide and prepaid options, and TrimRx panels show GLP-1 from $174 and GLP-1/GIP from $279 with different FAQ pricing. Those are distinct products and commitments. Remedy’s current public dollar quote was not established here; its care bundle uses 28-day billing.

Compounded medications are not FDA-approved or reviewed for safety, effectiveness, or quality. A prescription is never guaranteed; eligibility is determined by an independent licensed provider.